To foster high-quality oral and written presentations at IASLC conferences, an implementation team will conduct a review of abstract titles and provide suggestions based on the  IASLC Language Guide. We encourage you to review the Guide prior to submitting your abstract, to minimize later suggestions or edits and to help facilitate mutually respectful communication.   

Encore Submission: 
An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the abstract. Submitters are required to list any previously presented abstracts in the introduction of the abstract. 

Financial disclosure and affiliation information is required for the presenting author.  For reference, here is a link to the disclosure form. 

Publication:
Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference website. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation. 

Education Awards:
These awards are presented to individuals with high scoring abstracts who meet categorical eligibility criteria and who apply. Applications must be completed by the abstract and education award submission deadline April 5, 2024 (23:59 PDT). 

Definition: 
Plagiarism encompasses all of the following: 

1. Direct: intentionally submitting another person’s words or ideas verbatim as one’s own; 
2. Self-plagiarism: submitting work that has been previously published or presented; 
3. Mosaic plagiarism: stringing together portions of text from other sources; and 
4. Lack of attribution: failing to appropriately identify and cite sources for language or ideas that are incorporated. 

For more information see: Das N, Panjabi M. Plagiarism: Why is it such a big issue for medical writers? Perspect Clin Res. 2011;2(2):67–71. doi:10.4103/2229-3485.80370  

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121267/  

• Screening: IASLC screens all abstracts using anti-plagiarism software. Abstracts identified as having high levels of plagiarized content will be evaluated by IASLC staff and appropriate actions taken. 
  
  
• Penalties for plagiarism may include: Rejection of abstract, and/or author(s) banned from making presentations at IASLC conferences. 

Financial disclosure and affiliation information is required for the presenting author.  

For reference, here is a link to the disclosure form.   

Independence of Educational Activities Policy 

• Employees of ACCME defined ineligible companies are prohibited from presenting educational content for Continuing Medical Education. Consequently, employees of ineligible companies are prohibited from giving presentations during accredited CME sessions (e.g., Presidential and plenary symposia, invited educational sessions).  
• In situations where the presenting author is an employee of an ineligible company, the abstract will automatically be considered for a poster or e-poster.  
• Presenting authors must be registered for WCLC 2024 independent of an ineligible company, except for employees of ineligible companies, who are allowed to be registered by their employers.  
• The presenting author must control all content. Ineligible companies may not influence scientific content by requiring the use of company slide decks or other materials. Scientific data generated by industry sponsored research is permissible.  
• Content of educational activities must be well-balanced, evidence based and unbiased. Generic names should be used to the extent possible.  
• Ineligible companies/commercial interests may not submit registration materials or fees on behalf of learners, faculty or others attendee types. 

An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the abstract. Submitters are required to list any previously presented abstracts in the introduction of the abstract. 

Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference proceedings. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation.  

Associated manuscripts for any abstract selected for presentation at WCLC can be submitted to a peer reviewed journal prior to presentation at WCLC but must not be published prior to the presentation at WCLC. Simultaneous publications are encouraged.  

Confidentiality
Upon submission to the WCLC, all abstracts and study data intended for presentation at the Conference are held in confidence. This confidentiality policy applies to previously presented abstracts at WCLC only with regard to new or updated data or information within the study.

Before the abstract information is made public in conjunction with the WCLC Conference, the following parties – the author, co-authors, research sponsor, journalists, and others – are prohibited from:

• Disclosing the information to the public or sharing it with entities that may make it public, such as news media
• Using the information for securities trading purposes or providing it to others for such purposes

Confidentiality restrictions are lifted when WCLC publishes the abstracts online in conjunction with the Conference. Once IASLC makes the abstract publicly available, the Confidentiality Policy becomes inactive, allowing authors to openly discuss their study findings. However, formal presentations, including slides, posters, and recordings of the study data, remain exclusive to WCLC.

In cases where an abstract or its data is released in a manner that violates WCLC’s Confidentiality Policy after submission, the abstract may become ineligible for inclusion in the WCLC Conference. Exceptional circumstances may be considered if an official Confidentiality Policy Exception is applicable.

Embargo 
All abstracts accepted for presentation with the exception of abstracts included in the WCLC press program will have their titles released on July 23, 2024 at 10:00 PDT and the full text released on August 14, 2024 at 10:00 PDT.  

Abstracts selected for inclusion in the WCLC press program, including Presidential Sessions abstracts, will be kept under embargo until either the time of the presentation or the beginning of the WCLC press conference in which it is presented, whichever comes first.